Basket | Login


Alzheimer Europe signs memorandum of understanding with ALCOVE, the Joint Action on Dementia

Wednesday 11 April 2012

On 11 and 12 April, Heike von Lützau-Hohlbein and Jean Georges, the Chairperson and Executive Director of Alzheimer Europe were invited to attend the Steering Committee Meeting of ALCOVE, the European Joint Action on Dementia.

ALCOVE stands for ¨ALzheimer's COoperative Valuation in Europe¨. It is a two year Joint Action (JA), which is co-financed by the European Commission and is managed by the Executive Agency for Health and Consumers (EAHC) within the framework of the Community's 2008-2013 public health programmes.

The Joint Action brings together 30 partners from 20 countries (Belgium, Cyprus, Czech Republic, Finland, France, Greece, Hungary, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Slovakia, Slovakia, Spain, Sweden and the UK), with the Haute Autorité de Santé (HAS) in France acting as coordinator.

Within ALCOVE, there are four core questions to be addressed:

  1. How to improve data for better knowledge about dementia prevalence?
  2. How to improve access to dementia diagnosis as early as possible?
  3. How to improve care for people living with dementia and particularly those with behavioural disorders?
  4. How to improve the rights of people with dementia, particularly with respect to advance declarations of will?

In order to answer these questions, the work of the project is divided into seven Work Packages. The desired anticipated main outcomes are:

  • The establishment of a sustainable European network for the exchange of experiences and knowledge at the level of health care institutions in order to improve quality of care and services.
  • To inform and advise decision-makers, health care professionals, care givers and citizens in general through convergent recommendations in terms of health policy, and
  • A reduction in the risks associated with psychotropic drugs, with a common focus on the use of psychotropic drugs, in particular antipsychotics.

At the meeting in Paris, Alzheimer Europe and the ALCOVE network signed a memorandum of understanding outlining the areas of collaboration.